- AU$14.64m
- AU$15.95m
- AU$14.61m
Annual balance sheet for ImpediMed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 40.7 | 45.7 | 24.6 | 22.2 | 15.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.38 | 4.38 | 3.2 | 3.65 | 4.68 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 46.7 | 51.9 | 29.5 | 27.5 | 23.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.418 | 1.95 | 1.45 | 0.883 | 0.647 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 58.7 | 68.7 | 47 | 41.7 | 34.7 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.24 | 5.85 | 4.66 | 5.66 | 6.18 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.66 | 7.86 | 6.24 | 21.2 | 24.5 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 51 | 60.9 | 40.7 | 20.5 | 10.2 |
| Total Liabilities & Shareholders' Equity | 58.7 | 68.7 | 47 | 41.7 | 34.7 |
| Total Common Shares Outstanding |